Sten Hellström

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives.

Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.

Lipid Technologies Provider AB develops, commercializes, and produces technologies for food products. It focuses on production of lipids & lipid formulations as well as on development of new applications and IPR in all business areas. The firm offers technology for drug delivery systems and skin care products. The company was founded in January 2001 and is headquartered in Karlshamn, Sweden

SHL Medical AB develops and manufactures medical devices. The company offers services to pharmaceutical and biotech companies. It also operates in the United States of America and Taiwan. SHL Medical was founded in 1986 and is headquartered in Nacka Strand, Sweden

Redeye AB is an equity research and investment banking firm headquartered in Stockholm, Sweden. The firm was founded in 1999 and is a subsidiary of Redhold AB. It provides corporate clients and investors with research on technology based businesses in the Nordic countries that compete in the global arena. Redeye seeks companies with disruptive technologies or ability to leverage existing technology to create new market opportunities.

Part of IQVIA Holdings, Inc., Läkemedelsstatistik AB is a Swedish company that conducts research on pharmaceutical drug companies. The company is based in Stockholm, Sweden. Läkemedelsstatistik was acquired by IQVIA, Inc., part of IQVIA Holdings, Inc. from February 26, 2010 on December 31, 2006.

Cogmed develops and markets software-based working memory training products for improved attention. The company's products are a unique combination of breakthrough research, original software design and effective support methodology. Cogmed is a privately held company founded in Stockholm, Sweden in 2001. The founders are neuroscientists at the Karolinska Institute in Stockholm and game developers. The firm's main markets are the United States and Sweden. In 2006 Cogmed established its U.S. offices in Naperville and Illinois. Cogmed works with practices across the United States and Canada. It also has partners in Japan, in several European countries, and around the world. Cogmed is involved in evidence-based cognitive training. The firm has research results, scientifically validated, showing that Cogmed training provides substantial and lasting improvements in attention, for people with poor working memory, in all age groups. That makes Cogmed's products the best-validated products on the market.

Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden.

Umeå Biotech Incubator AB is a biotechnical research and development company based in Umeå, Sweden. Part of Umea Universitet, Umeå Biotech Incubator AB engages in biotechnical research and development business. The CEO of the Swedish company is Tor Ny.

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden.

Vakona is a Swedish company that is developing a new biological drug for the treatment of acne. The drug is based on a bacterial enzyme and has the potential to significantly reduce treatment time and side effects such as skin irritation. The company's research is based on over a decade of work by Dr. Oleg Alexeyev and aims to provide an alternative to the long-term inefficacy of current acne therapies that rely on antibiotics. The company was founded by Oleg Alexeyev and has CEOs Mats Olof Strömqvist and Gabriella Persson.